Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
2,026
archived clinical trials in
Epilepsy

Search for Genes Influencing Childhood Absence Epilepsy (CAE) Study
Search for Genes Influencing Childhood Absence Epilepsy Study
Status: Enrolling
Updated:  5/31/2016
Icahn School of Medicine at Mount Sinai
mi
from
New York, NY
Search for Genes Influencing Childhood Absence Epilepsy (CAE) Study
Search for Genes Influencing Childhood Absence Epilepsy Study
Status: Enrolling
Updated: 5/31/2016
Icahn School of Medicine at Mount Sinai
mi
from
New York, NY
Click here to add this to my saved trials
Effects of Treating Obstructive Sleep Apnea in Epilepsy
Effects of Treating Obstructive Sleep Apnea in Epilepsy
Status: Enrolling
Updated:  7/20/2016
University of Michigan
mi
from
Ann Arbor, MI
Effects of Treating Obstructive Sleep Apnea in Epilepsy
Effects of Treating Obstructive Sleep Apnea in Epilepsy
Status: Enrolling
Updated: 7/20/2016
University of Michigan
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Effects of Treating Obstructive Sleep Apnea in Epilepsy
Effects of Treating Obstructive Sleep Apnea in Epilepsy
Status: Enrolling
Updated:  7/20/2016
Univ of North Carolina
mi
from
Chapel Hill, NC
Effects of Treating Obstructive Sleep Apnea in Epilepsy
Effects of Treating Obstructive Sleep Apnea in Epilepsy
Status: Enrolling
Updated: 7/20/2016
Univ of North Carolina
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
Effects of Treating Obstructive Sleep Apnea in Epilepsy
Effects of Treating Obstructive Sleep Apnea in Epilepsy
Status: Enrolling
Updated:  7/20/2016
Cleveland Clinic Foundation
mi
from
Cleveland, OH
Effects of Treating Obstructive Sleep Apnea in Epilepsy
Effects of Treating Obstructive Sleep Apnea in Epilepsy
Status: Enrolling
Updated: 7/20/2016
Cleveland Clinic Foundation
mi
from
Cleveland, OH
Click here to add this to my saved trials
Effects of Treating Obstructive Sleep Apnea in Epilepsy
Effects of Treating Obstructive Sleep Apnea in Epilepsy
Status: Enrolling
Updated:  7/20/2016
Vanderbilt University
mi
from
Nashville, TN
Effects of Treating Obstructive Sleep Apnea in Epilepsy
Effects of Treating Obstructive Sleep Apnea in Epilepsy
Status: Enrolling
Updated: 7/20/2016
Vanderbilt University
mi
from
Nashville, TN
Click here to add this to my saved trials
Patients With Epilepsy Taking LAMICTAL Immediate-Release Who Switch To Extended-Release Formulation And Vice Versa
An Open-label, Double Conversion Study to Characterize the Pharmacokinetics of Lamotrigine When Switching Patients With Epilepsy on LAMICTAL Immediate-release to Extended-release Formulation and Vice Versa
Status: Enrolling
Updated:  9/22/2016
GSK Investigational Site
mi
from
Anniston, AL
Patients With Epilepsy Taking LAMICTAL Immediate-Release Who Switch To Extended-Release Formulation And Vice Versa
An Open-label, Double Conversion Study to Characterize the Pharmacokinetics of Lamotrigine When Switching Patients With Epilepsy on LAMICTAL Immediate-release to Extended-release Formulation and Vice Versa
Status: Enrolling
Updated: 9/22/2016
GSK Investigational Site
mi
from
Anniston, AL
Click here to add this to my saved trials
Patients With Epilepsy Taking LAMICTAL Immediate-Release Who Switch To Extended-Release Formulation And Vice Versa
An Open-label, Double Conversion Study to Characterize the Pharmacokinetics of Lamotrigine When Switching Patients With Epilepsy on LAMICTAL Immediate-release to Extended-release Formulation and Vice Versa
Status: Enrolling
Updated:  9/22/2016
GSK Investigational Site
mi
from
Sun City, AZ
Patients With Epilepsy Taking LAMICTAL Immediate-Release Who Switch To Extended-Release Formulation And Vice Versa
An Open-label, Double Conversion Study to Characterize the Pharmacokinetics of Lamotrigine When Switching Patients With Epilepsy on LAMICTAL Immediate-release to Extended-release Formulation and Vice Versa
Status: Enrolling
Updated: 9/22/2016
GSK Investigational Site
mi
from
Sun City, AZ
Click here to add this to my saved trials
Patients With Epilepsy Taking LAMICTAL Immediate-Release Who Switch To Extended-Release Formulation And Vice Versa
An Open-label, Double Conversion Study to Characterize the Pharmacokinetics of Lamotrigine When Switching Patients With Epilepsy on LAMICTAL Immediate-release to Extended-release Formulation and Vice Versa
Status: Enrolling
Updated:  9/22/2016
GSK Investigational Site
mi
from
Lexington, KY
Patients With Epilepsy Taking LAMICTAL Immediate-Release Who Switch To Extended-Release Formulation And Vice Versa
An Open-label, Double Conversion Study to Characterize the Pharmacokinetics of Lamotrigine When Switching Patients With Epilepsy on LAMICTAL Immediate-release to Extended-release Formulation and Vice Versa
Status: Enrolling
Updated: 9/22/2016
GSK Investigational Site
mi
from
Lexington, KY
Click here to add this to my saved trials
Patients With Epilepsy Taking LAMICTAL Immediate-Release Who Switch To Extended-Release Formulation And Vice Versa
An Open-label, Double Conversion Study to Characterize the Pharmacokinetics of Lamotrigine When Switching Patients With Epilepsy on LAMICTAL Immediate-release to Extended-release Formulation and Vice Versa
Status: Enrolling
Updated:  9/22/2016
GSK Investigational Site
mi
from
Boston, MA
Patients With Epilepsy Taking LAMICTAL Immediate-Release Who Switch To Extended-Release Formulation And Vice Versa
An Open-label, Double Conversion Study to Characterize the Pharmacokinetics of Lamotrigine When Switching Patients With Epilepsy on LAMICTAL Immediate-release to Extended-release Formulation and Vice Versa
Status: Enrolling
Updated: 9/22/2016
GSK Investigational Site
mi
from
Boston, MA
Click here to add this to my saved trials
Patients With Epilepsy Taking LAMICTAL Immediate-Release Who Switch To Extended-Release Formulation And Vice Versa
An Open-label, Double Conversion Study to Characterize the Pharmacokinetics of Lamotrigine When Switching Patients With Epilepsy on LAMICTAL Immediate-release to Extended-release Formulation and Vice Versa
Status: Enrolling
Updated:  9/22/2016
GSK Investigational Site
mi
from
Reno, NV
Patients With Epilepsy Taking LAMICTAL Immediate-Release Who Switch To Extended-Release Formulation And Vice Versa
An Open-label, Double Conversion Study to Characterize the Pharmacokinetics of Lamotrigine When Switching Patients With Epilepsy on LAMICTAL Immediate-release to Extended-release Formulation and Vice Versa
Status: Enrolling
Updated: 9/22/2016
GSK Investigational Site
mi
from
Reno, NV
Click here to add this to my saved trials
Patients With Epilepsy Taking LAMICTAL Immediate-Release Who Switch To Extended-Release Formulation And Vice Versa
An Open-label, Double Conversion Study to Characterize the Pharmacokinetics of Lamotrigine When Switching Patients With Epilepsy on LAMICTAL Immediate-release to Extended-release Formulation and Vice Versa
Status: Enrolling
Updated:  9/22/2016
GSK Investigational Site
mi
from
New York, NY
Patients With Epilepsy Taking LAMICTAL Immediate-Release Who Switch To Extended-Release Formulation And Vice Versa
An Open-label, Double Conversion Study to Characterize the Pharmacokinetics of Lamotrigine When Switching Patients With Epilepsy on LAMICTAL Immediate-release to Extended-release Formulation and Vice Versa
Status: Enrolling
Updated: 9/22/2016
GSK Investigational Site
mi
from
New York, NY
Click here to add this to my saved trials
Patients With Epilepsy Taking LAMICTAL Immediate-Release Who Switch To Extended-Release Formulation And Vice Versa
An Open-label, Double Conversion Study to Characterize the Pharmacokinetics of Lamotrigine When Switching Patients With Epilepsy on LAMICTAL Immediate-release to Extended-release Formulation and Vice Versa
Status: Enrolling
Updated:  9/22/2016
GSK Investigational Site
mi
from
Toledo, OH
Patients With Epilepsy Taking LAMICTAL Immediate-Release Who Switch To Extended-Release Formulation And Vice Versa
An Open-label, Double Conversion Study to Characterize the Pharmacokinetics of Lamotrigine When Switching Patients With Epilepsy on LAMICTAL Immediate-release to Extended-release Formulation and Vice Versa
Status: Enrolling
Updated: 9/22/2016
GSK Investigational Site
mi
from
Toledo, OH
Click here to add this to my saved trials
Patients With Epilepsy Taking LAMICTAL Immediate-Release Who Switch To Extended-Release Formulation And Vice Versa
An Open-label, Double Conversion Study to Characterize the Pharmacokinetics of Lamotrigine When Switching Patients With Epilepsy on LAMICTAL Immediate-release to Extended-release Formulation and Vice Versa
Status: Enrolling
Updated:  9/22/2016
GSK Investigational Site
mi
from
Philadelphia, PA
Patients With Epilepsy Taking LAMICTAL Immediate-Release Who Switch To Extended-Release Formulation And Vice Versa
An Open-label, Double Conversion Study to Characterize the Pharmacokinetics of Lamotrigine When Switching Patients With Epilepsy on LAMICTAL Immediate-release to Extended-release Formulation and Vice Versa
Status: Enrolling
Updated: 9/22/2016
GSK Investigational Site
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Patients With Epilepsy Taking LAMICTAL Immediate-Release Who Switch To Extended-Release Formulation And Vice Versa
An Open-label, Double Conversion Study to Characterize the Pharmacokinetics of Lamotrigine When Switching Patients With Epilepsy on LAMICTAL Immediate-release to Extended-release Formulation and Vice Versa
Status: Enrolling
Updated:  9/22/2016
GSK Investigational Site
mi
from
Nashville, TN
Patients With Epilepsy Taking LAMICTAL Immediate-Release Who Switch To Extended-Release Formulation And Vice Versa
An Open-label, Double Conversion Study to Characterize the Pharmacokinetics of Lamotrigine When Switching Patients With Epilepsy on LAMICTAL Immediate-release to Extended-release Formulation and Vice Versa
Status: Enrolling
Updated: 9/22/2016
GSK Investigational Site
mi
from
Nashville, TN
Click here to add this to my saved trials
Patients With Epilepsy Taking LAMICTAL Immediate-Release Who Switch To Extended-Release Formulation And Vice Versa
An Open-label, Double Conversion Study to Characterize the Pharmacokinetics of Lamotrigine When Switching Patients With Epilepsy on LAMICTAL Immediate-release to Extended-release Formulation and Vice Versa
Status: Enrolling
Updated:  9/22/2016
GSK Investigational Site
mi
from
Dallas, TX
Patients With Epilepsy Taking LAMICTAL Immediate-Release Who Switch To Extended-Release Formulation And Vice Versa
An Open-label, Double Conversion Study to Characterize the Pharmacokinetics of Lamotrigine When Switching Patients With Epilepsy on LAMICTAL Immediate-release to Extended-release Formulation and Vice Versa
Status: Enrolling
Updated: 9/22/2016
GSK Investigational Site
mi
from
Dallas, TX
Click here to add this to my saved trials
Patients With Epilepsy Taking LAMICTAL Immediate-Release Who Switch To Extended-Release Formulation And Vice Versa
An Open-label, Double Conversion Study to Characterize the Pharmacokinetics of Lamotrigine When Switching Patients With Epilepsy on LAMICTAL Immediate-release to Extended-release Formulation and Vice Versa
Status: Enrolling
Updated:  9/22/2016
GSK Investigational Site
mi
from
Richmond, VA
Patients With Epilepsy Taking LAMICTAL Immediate-Release Who Switch To Extended-Release Formulation And Vice Versa
An Open-label, Double Conversion Study to Characterize the Pharmacokinetics of Lamotrigine When Switching Patients With Epilepsy on LAMICTAL Immediate-release to Extended-release Formulation and Vice Versa
Status: Enrolling
Updated: 9/22/2016
GSK Investigational Site
mi
from
Richmond, VA
Click here to add this to my saved trials
Study Evaluating LAMICTAL Extended-Release Therapy Added To Current Seizure Treatments In Patients With Partial Seizures
A Multicenter, Double-Blind, Randomized, Parallel-group Evaluation of LAMICTAL Extended-release Adjunctive Therapy in Subjects With Partial Seizures
Status: Enrolling
Updated:  12/2/2016
GSK Investigational Site
mi
from
Anniston, AL
Study Evaluating LAMICTAL Extended-Release Therapy Added To Current Seizure Treatments In Patients With Partial Seizures
A Multicenter, Double-Blind, Randomized, Parallel-group Evaluation of LAMICTAL Extended-release Adjunctive Therapy in Subjects With Partial Seizures
Status: Enrolling
Updated: 12/2/2016
GSK Investigational Site
mi
from
Anniston, AL
Click here to add this to my saved trials
Study Evaluating LAMICTAL Extended-Release Therapy Added To Current Seizure Treatments In Patients With Partial Seizures
A Multicenter, Double-Blind, Randomized, Parallel-group Evaluation of LAMICTAL Extended-release Adjunctive Therapy in Subjects With Partial Seizures
Status: Enrolling
Updated:  12/2/2016
GSK Investigational Site
mi
from
Birmingham, AL
Study Evaluating LAMICTAL Extended-Release Therapy Added To Current Seizure Treatments In Patients With Partial Seizures
A Multicenter, Double-Blind, Randomized, Parallel-group Evaluation of LAMICTAL Extended-release Adjunctive Therapy in Subjects With Partial Seizures
Status: Enrolling
Updated: 12/2/2016
GSK Investigational Site
mi
from
Birmingham, AL
Click here to add this to my saved trials
Study Evaluating LAMICTAL Extended-Release Therapy Added To Current Seizure Treatments In Patients With Partial Seizures
A Multicenter, Double-Blind, Randomized, Parallel-group Evaluation of LAMICTAL Extended-release Adjunctive Therapy in Subjects With Partial Seizures
Status: Enrolling
Updated:  12/2/2016
GSK Investigational Site
mi
from
Northport, AL
Study Evaluating LAMICTAL Extended-Release Therapy Added To Current Seizure Treatments In Patients With Partial Seizures
A Multicenter, Double-Blind, Randomized, Parallel-group Evaluation of LAMICTAL Extended-release Adjunctive Therapy in Subjects With Partial Seizures
Status: Enrolling
Updated: 12/2/2016
GSK Investigational Site
mi
from
Northport, AL
Click here to add this to my saved trials
Study Evaluating LAMICTAL Extended-Release Therapy Added To Current Seizure Treatments In Patients With Partial Seizures
A Multicenter, Double-Blind, Randomized, Parallel-group Evaluation of LAMICTAL Extended-release Adjunctive Therapy in Subjects With Partial Seizures
Status: Enrolling
Updated:  12/2/2016
GSK Investigational Site
mi
from
Tuscaloosa, AL
Study Evaluating LAMICTAL Extended-Release Therapy Added To Current Seizure Treatments In Patients With Partial Seizures
A Multicenter, Double-Blind, Randomized, Parallel-group Evaluation of LAMICTAL Extended-release Adjunctive Therapy in Subjects With Partial Seizures
Status: Enrolling
Updated: 12/2/2016
GSK Investigational Site
mi
from
Tuscaloosa, AL
Click here to add this to my saved trials
Study Evaluating LAMICTAL Extended-Release Therapy Added To Current Seizure Treatments In Patients With Partial Seizures
A Multicenter, Double-Blind, Randomized, Parallel-group Evaluation of LAMICTAL Extended-release Adjunctive Therapy in Subjects With Partial Seizures
Status: Enrolling
Updated:  12/2/2016
GSK Investigational Site
mi
from
Mesa, AZ
Study Evaluating LAMICTAL Extended-Release Therapy Added To Current Seizure Treatments In Patients With Partial Seizures
A Multicenter, Double-Blind, Randomized, Parallel-group Evaluation of LAMICTAL Extended-release Adjunctive Therapy in Subjects With Partial Seizures
Status: Enrolling
Updated: 12/2/2016
GSK Investigational Site
mi
from
Mesa, AZ
Click here to add this to my saved trials
Study Evaluating LAMICTAL Extended-Release Therapy Added To Current Seizure Treatments In Patients With Partial Seizures
A Multicenter, Double-Blind, Randomized, Parallel-group Evaluation of LAMICTAL Extended-release Adjunctive Therapy in Subjects With Partial Seizures
Status: Enrolling
Updated:  12/2/2016
GSK Investigational Site
mi
from
Phoenix, AZ
Study Evaluating LAMICTAL Extended-Release Therapy Added To Current Seizure Treatments In Patients With Partial Seizures
A Multicenter, Double-Blind, Randomized, Parallel-group Evaluation of LAMICTAL Extended-release Adjunctive Therapy in Subjects With Partial Seizures
Status: Enrolling
Updated: 12/2/2016
GSK Investigational Site
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Study Evaluating LAMICTAL Extended-Release Therapy Added To Current Seizure Treatments In Patients With Partial Seizures
A Multicenter, Double-Blind, Randomized, Parallel-group Evaluation of LAMICTAL Extended-release Adjunctive Therapy in Subjects With Partial Seizures
Status: Enrolling
Updated:  12/2/2016
GSK Investigational Site
mi
from
Scottsdale, AZ
Study Evaluating LAMICTAL Extended-Release Therapy Added To Current Seizure Treatments In Patients With Partial Seizures
A Multicenter, Double-Blind, Randomized, Parallel-group Evaluation of LAMICTAL Extended-release Adjunctive Therapy in Subjects With Partial Seizures
Status: Enrolling
Updated: 12/2/2016
GSK Investigational Site
mi
from
Scottsdale, AZ
Click here to add this to my saved trials
Study Evaluating LAMICTAL Extended-Release Therapy Added To Current Seizure Treatments In Patients With Partial Seizures
A Multicenter, Double-Blind, Randomized, Parallel-group Evaluation of LAMICTAL Extended-release Adjunctive Therapy in Subjects With Partial Seizures
Status: Enrolling
Updated:  12/2/2016
GSK Investigational Site
mi
from
Sun City, AZ
Study Evaluating LAMICTAL Extended-Release Therapy Added To Current Seizure Treatments In Patients With Partial Seizures
A Multicenter, Double-Blind, Randomized, Parallel-group Evaluation of LAMICTAL Extended-release Adjunctive Therapy in Subjects With Partial Seizures
Status: Enrolling
Updated: 12/2/2016
GSK Investigational Site
mi
from
Sun City, AZ
Click here to add this to my saved trials
Study Evaluating LAMICTAL Extended-Release Therapy Added To Current Seizure Treatments In Patients With Partial Seizures
A Multicenter, Double-Blind, Randomized, Parallel-group Evaluation of LAMICTAL Extended-release Adjunctive Therapy in Subjects With Partial Seizures
Status: Enrolling
Updated:  12/2/2016
GSK Investigational Site
mi
from
Tucson, AZ
Study Evaluating LAMICTAL Extended-Release Therapy Added To Current Seizure Treatments In Patients With Partial Seizures
A Multicenter, Double-Blind, Randomized, Parallel-group Evaluation of LAMICTAL Extended-release Adjunctive Therapy in Subjects With Partial Seizures
Status: Enrolling
Updated: 12/2/2016
GSK Investigational Site
mi
from
Tucson, AZ
Click here to add this to my saved trials
Study Evaluating LAMICTAL Extended-Release Therapy Added To Current Seizure Treatments In Patients With Partial Seizures
A Multicenter, Double-Blind, Randomized, Parallel-group Evaluation of LAMICTAL Extended-release Adjunctive Therapy in Subjects With Partial Seizures
Status: Enrolling
Updated:  12/2/2016
GSK Investigational Site
mi
from
Little Rock, AR
Study Evaluating LAMICTAL Extended-Release Therapy Added To Current Seizure Treatments In Patients With Partial Seizures
A Multicenter, Double-Blind, Randomized, Parallel-group Evaluation of LAMICTAL Extended-release Adjunctive Therapy in Subjects With Partial Seizures
Status: Enrolling
Updated: 12/2/2016
GSK Investigational Site
mi
from
Little Rock, AR
Click here to add this to my saved trials
Study Evaluating LAMICTAL Extended-Release Therapy Added To Current Seizure Treatments In Patients With Partial Seizures
A Multicenter, Double-Blind, Randomized, Parallel-group Evaluation of LAMICTAL Extended-release Adjunctive Therapy in Subjects With Partial Seizures
Status: Enrolling
Updated:  12/2/2016
GSK Investigational Site
mi
from
Los Angeles, CA
Study Evaluating LAMICTAL Extended-Release Therapy Added To Current Seizure Treatments In Patients With Partial Seizures
A Multicenter, Double-Blind, Randomized, Parallel-group Evaluation of LAMICTAL Extended-release Adjunctive Therapy in Subjects With Partial Seizures
Status: Enrolling
Updated: 12/2/2016
GSK Investigational Site
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Study Evaluating LAMICTAL Extended-Release Therapy Added To Current Seizure Treatments In Patients With Partial Seizures
A Multicenter, Double-Blind, Randomized, Parallel-group Evaluation of LAMICTAL Extended-release Adjunctive Therapy in Subjects With Partial Seizures
Status: Enrolling
Updated:  12/2/2016
GSK Investigational Site
mi
from
Newport Beach, CA
Study Evaluating LAMICTAL Extended-Release Therapy Added To Current Seizure Treatments In Patients With Partial Seizures
A Multicenter, Double-Blind, Randomized, Parallel-group Evaluation of LAMICTAL Extended-release Adjunctive Therapy in Subjects With Partial Seizures
Status: Enrolling
Updated: 12/2/2016
GSK Investigational Site
mi
from
Newport Beach, CA
Click here to add this to my saved trials
Study Evaluating LAMICTAL Extended-Release Therapy Added To Current Seizure Treatments In Patients With Partial Seizures
A Multicenter, Double-Blind, Randomized, Parallel-group Evaluation of LAMICTAL Extended-release Adjunctive Therapy in Subjects With Partial Seizures
Status: Enrolling
Updated:  12/2/2016
GSK Investigational Site
mi
from
Santa Monica, CA
Study Evaluating LAMICTAL Extended-Release Therapy Added To Current Seizure Treatments In Patients With Partial Seizures
A Multicenter, Double-Blind, Randomized, Parallel-group Evaluation of LAMICTAL Extended-release Adjunctive Therapy in Subjects With Partial Seizures
Status: Enrolling
Updated: 12/2/2016
GSK Investigational Site
mi
from
Santa Monica, CA
Click here to add this to my saved trials
Study Evaluating LAMICTAL Extended-Release Therapy Added To Current Seizure Treatments In Patients With Partial Seizures
A Multicenter, Double-Blind, Randomized, Parallel-group Evaluation of LAMICTAL Extended-release Adjunctive Therapy in Subjects With Partial Seizures
Status: Enrolling
Updated:  12/2/2016
GSK Investigational Site
mi
from
Sepuldeva, CA
Study Evaluating LAMICTAL Extended-Release Therapy Added To Current Seizure Treatments In Patients With Partial Seizures
A Multicenter, Double-Blind, Randomized, Parallel-group Evaluation of LAMICTAL Extended-release Adjunctive Therapy in Subjects With Partial Seizures
Status: Enrolling
Updated: 12/2/2016
GSK Investigational Site
mi
from
Sepuldeva, CA
Click here to add this to my saved trials
Study Evaluating LAMICTAL Extended-Release Therapy Added To Current Seizure Treatments In Patients With Partial Seizures
A Multicenter, Double-Blind, Randomized, Parallel-group Evaluation of LAMICTAL Extended-release Adjunctive Therapy in Subjects With Partial Seizures
Status: Enrolling
Updated:  12/2/2016
GSK Investigational Site
mi
from
Washington,
Study Evaluating LAMICTAL Extended-Release Therapy Added To Current Seizure Treatments In Patients With Partial Seizures
A Multicenter, Double-Blind, Randomized, Parallel-group Evaluation of LAMICTAL Extended-release Adjunctive Therapy in Subjects With Partial Seizures
Status: Enrolling
Updated: 12/2/2016
GSK Investigational Site
mi
from
Washington,
Click here to add this to my saved trials
Study Evaluating LAMICTAL Extended-Release Therapy Added To Current Seizure Treatments In Patients With Partial Seizures
A Multicenter, Double-Blind, Randomized, Parallel-group Evaluation of LAMICTAL Extended-release Adjunctive Therapy in Subjects With Partial Seizures
Status: Enrolling
Updated:  12/2/2016
GSK Investigational Site
mi
from
Hollywood, FL
Study Evaluating LAMICTAL Extended-Release Therapy Added To Current Seizure Treatments In Patients With Partial Seizures
A Multicenter, Double-Blind, Randomized, Parallel-group Evaluation of LAMICTAL Extended-release Adjunctive Therapy in Subjects With Partial Seizures
Status: Enrolling
Updated: 12/2/2016
GSK Investigational Site
mi
from
Hollywood, FL
Click here to add this to my saved trials
Study Evaluating LAMICTAL Extended-Release Therapy Added To Current Seizure Treatments In Patients With Partial Seizures
A Multicenter, Double-Blind, Randomized, Parallel-group Evaluation of LAMICTAL Extended-release Adjunctive Therapy in Subjects With Partial Seizures
Status: Enrolling
Updated:  12/2/2016
GSK Investigational Site
mi
from
Maitland, FL
Study Evaluating LAMICTAL Extended-Release Therapy Added To Current Seizure Treatments In Patients With Partial Seizures
A Multicenter, Double-Blind, Randomized, Parallel-group Evaluation of LAMICTAL Extended-release Adjunctive Therapy in Subjects With Partial Seizures
Status: Enrolling
Updated: 12/2/2016
GSK Investigational Site
mi
from
Maitland, FL
Click here to add this to my saved trials
Study Evaluating LAMICTAL Extended-Release Therapy Added To Current Seizure Treatments In Patients With Partial Seizures
A Multicenter, Double-Blind, Randomized, Parallel-group Evaluation of LAMICTAL Extended-release Adjunctive Therapy in Subjects With Partial Seizures
Status: Enrolling
Updated:  12/2/2016
GSK Investigational Site
mi
from
Ocala, FL
Study Evaluating LAMICTAL Extended-Release Therapy Added To Current Seizure Treatments In Patients With Partial Seizures
A Multicenter, Double-Blind, Randomized, Parallel-group Evaluation of LAMICTAL Extended-release Adjunctive Therapy in Subjects With Partial Seizures
Status: Enrolling
Updated: 12/2/2016
GSK Investigational Site
mi
from
Ocala, FL
Click here to add this to my saved trials
Study Evaluating LAMICTAL Extended-Release Therapy Added To Current Seizure Treatments In Patients With Partial Seizures
A Multicenter, Double-Blind, Randomized, Parallel-group Evaluation of LAMICTAL Extended-release Adjunctive Therapy in Subjects With Partial Seizures
Status: Enrolling
Updated:  12/2/2016
GSK Investigational Site
mi
from
Tallahassee, FL
Study Evaluating LAMICTAL Extended-Release Therapy Added To Current Seizure Treatments In Patients With Partial Seizures
A Multicenter, Double-Blind, Randomized, Parallel-group Evaluation of LAMICTAL Extended-release Adjunctive Therapy in Subjects With Partial Seizures
Status: Enrolling
Updated: 12/2/2016
GSK Investigational Site
mi
from
Tallahassee, FL
Click here to add this to my saved trials
Study Evaluating LAMICTAL Extended-Release Therapy Added To Current Seizure Treatments In Patients With Partial Seizures
A Multicenter, Double-Blind, Randomized, Parallel-group Evaluation of LAMICTAL Extended-release Adjunctive Therapy in Subjects With Partial Seizures
Status: Enrolling
Updated:  12/2/2016
GSK Investigational Site
mi
from
Tampa, FL
Study Evaluating LAMICTAL Extended-Release Therapy Added To Current Seizure Treatments In Patients With Partial Seizures
A Multicenter, Double-Blind, Randomized, Parallel-group Evaluation of LAMICTAL Extended-release Adjunctive Therapy in Subjects With Partial Seizures
Status: Enrolling
Updated: 12/2/2016
GSK Investigational Site
mi
from
Tampa, FL
Click here to add this to my saved trials
Study Evaluating LAMICTAL Extended-Release Therapy Added To Current Seizure Treatments In Patients With Partial Seizures
A Multicenter, Double-Blind, Randomized, Parallel-group Evaluation of LAMICTAL Extended-release Adjunctive Therapy in Subjects With Partial Seizures
Status: Enrolling
Updated:  12/2/2016
GSK Investigational Site
mi
from
Atlanta, GA
Study Evaluating LAMICTAL Extended-Release Therapy Added To Current Seizure Treatments In Patients With Partial Seizures
A Multicenter, Double-Blind, Randomized, Parallel-group Evaluation of LAMICTAL Extended-release Adjunctive Therapy in Subjects With Partial Seizures
Status: Enrolling
Updated: 12/2/2016
GSK Investigational Site
mi
from
Atlanta, GA
Click here to add this to my saved trials
Study Evaluating LAMICTAL Extended-Release Therapy Added To Current Seizure Treatments In Patients With Partial Seizures
A Multicenter, Double-Blind, Randomized, Parallel-group Evaluation of LAMICTAL Extended-release Adjunctive Therapy in Subjects With Partial Seizures
Status: Enrolling
Updated:  12/2/2016
GSK Investigational Site
mi
from
Augusta, GA
Study Evaluating LAMICTAL Extended-Release Therapy Added To Current Seizure Treatments In Patients With Partial Seizures
A Multicenter, Double-Blind, Randomized, Parallel-group Evaluation of LAMICTAL Extended-release Adjunctive Therapy in Subjects With Partial Seizures
Status: Enrolling
Updated: 12/2/2016
GSK Investigational Site
mi
from
Augusta, GA
Click here to add this to my saved trials
Study Evaluating LAMICTAL Extended-Release Therapy Added To Current Seizure Treatments In Patients With Partial Seizures
A Multicenter, Double-Blind, Randomized, Parallel-group Evaluation of LAMICTAL Extended-release Adjunctive Therapy in Subjects With Partial Seizures
Status: Enrolling
Updated:  12/2/2016
GSK Investigational Site
mi
from
Austell, GA
Study Evaluating LAMICTAL Extended-Release Therapy Added To Current Seizure Treatments In Patients With Partial Seizures
A Multicenter, Double-Blind, Randomized, Parallel-group Evaluation of LAMICTAL Extended-release Adjunctive Therapy in Subjects With Partial Seizures
Status: Enrolling
Updated: 12/2/2016
GSK Investigational Site
mi
from
Austell, GA
Click here to add this to my saved trials
Study Evaluating LAMICTAL Extended-Release Therapy Added To Current Seizure Treatments In Patients With Partial Seizures
A Multicenter, Double-Blind, Randomized, Parallel-group Evaluation of LAMICTAL Extended-release Adjunctive Therapy in Subjects With Partial Seizures
Status: Enrolling
Updated:  12/2/2016
GSK Investigational Site
mi
from
Savannah, GA
Study Evaluating LAMICTAL Extended-Release Therapy Added To Current Seizure Treatments In Patients With Partial Seizures
A Multicenter, Double-Blind, Randomized, Parallel-group Evaluation of LAMICTAL Extended-release Adjunctive Therapy in Subjects With Partial Seizures
Status: Enrolling
Updated: 12/2/2016
GSK Investigational Site
mi
from
Savannah, GA
Click here to add this to my saved trials
Study Evaluating LAMICTAL Extended-Release Therapy Added To Current Seizure Treatments In Patients With Partial Seizures
A Multicenter, Double-Blind, Randomized, Parallel-group Evaluation of LAMICTAL Extended-release Adjunctive Therapy in Subjects With Partial Seizures
Status: Enrolling
Updated:  12/2/2016
GSK Investigational Site
mi
from
Chicago, IL
Study Evaluating LAMICTAL Extended-Release Therapy Added To Current Seizure Treatments In Patients With Partial Seizures
A Multicenter, Double-Blind, Randomized, Parallel-group Evaluation of LAMICTAL Extended-release Adjunctive Therapy in Subjects With Partial Seizures
Status: Enrolling
Updated: 12/2/2016
GSK Investigational Site
mi
from
Chicago, IL
Click here to add this to my saved trials
Study Evaluating LAMICTAL Extended-Release Therapy Added To Current Seizure Treatments In Patients With Partial Seizures
A Multicenter, Double-Blind, Randomized, Parallel-group Evaluation of LAMICTAL Extended-release Adjunctive Therapy in Subjects With Partial Seizures
Status: Enrolling
Updated:  12/2/2016
GSK Investigational Site
mi
from
Flossmoor, IL
Study Evaluating LAMICTAL Extended-Release Therapy Added To Current Seizure Treatments In Patients With Partial Seizures
A Multicenter, Double-Blind, Randomized, Parallel-group Evaluation of LAMICTAL Extended-release Adjunctive Therapy in Subjects With Partial Seizures
Status: Enrolling
Updated: 12/2/2016
GSK Investigational Site
mi
from
Flossmoor, IL
Click here to add this to my saved trials
Study Evaluating LAMICTAL Extended-Release Therapy Added To Current Seizure Treatments In Patients With Partial Seizures
A Multicenter, Double-Blind, Randomized, Parallel-group Evaluation of LAMICTAL Extended-release Adjunctive Therapy in Subjects With Partial Seizures
Status: Enrolling
Updated:  12/2/2016
GSK Investigational Site
mi
from
Springfield, IL
Study Evaluating LAMICTAL Extended-Release Therapy Added To Current Seizure Treatments In Patients With Partial Seizures
A Multicenter, Double-Blind, Randomized, Parallel-group Evaluation of LAMICTAL Extended-release Adjunctive Therapy in Subjects With Partial Seizures
Status: Enrolling
Updated: 12/2/2016
GSK Investigational Site
mi
from
Springfield, IL
Click here to add this to my saved trials
Study Evaluating LAMICTAL Extended-Release Therapy Added To Current Seizure Treatments In Patients With Partial Seizures
A Multicenter, Double-Blind, Randomized, Parallel-group Evaluation of LAMICTAL Extended-release Adjunctive Therapy in Subjects With Partial Seizures
Status: Enrolling
Updated:  12/2/2016
GSK Investigational Site
mi
from
Des Moines, IA
Study Evaluating LAMICTAL Extended-Release Therapy Added To Current Seizure Treatments In Patients With Partial Seizures
A Multicenter, Double-Blind, Randomized, Parallel-group Evaluation of LAMICTAL Extended-release Adjunctive Therapy in Subjects With Partial Seizures
Status: Enrolling
Updated: 12/2/2016
GSK Investigational Site
mi
from
Des Moines, IA
Click here to add this to my saved trials
Study Evaluating LAMICTAL Extended-Release Therapy Added To Current Seizure Treatments In Patients With Partial Seizures
A Multicenter, Double-Blind, Randomized, Parallel-group Evaluation of LAMICTAL Extended-release Adjunctive Therapy in Subjects With Partial Seizures
Status: Enrolling
Updated:  12/2/2016
GSK Investigational Site
mi
from
Wichita, KA
Study Evaluating LAMICTAL Extended-Release Therapy Added To Current Seizure Treatments In Patients With Partial Seizures
A Multicenter, Double-Blind, Randomized, Parallel-group Evaluation of LAMICTAL Extended-release Adjunctive Therapy in Subjects With Partial Seizures
Status: Enrolling
Updated: 12/2/2016
GSK Investigational Site
mi
from
Wichita, KA
Click here to add this to my saved trials
Study Evaluating LAMICTAL Extended-Release Therapy Added To Current Seizure Treatments In Patients With Partial Seizures
A Multicenter, Double-Blind, Randomized, Parallel-group Evaluation of LAMICTAL Extended-release Adjunctive Therapy in Subjects With Partial Seizures
Status: Enrolling
Updated:  12/2/2016
GSK Investigational Site
mi
from
Crestview Hills, KY
Study Evaluating LAMICTAL Extended-Release Therapy Added To Current Seizure Treatments In Patients With Partial Seizures
A Multicenter, Double-Blind, Randomized, Parallel-group Evaluation of LAMICTAL Extended-release Adjunctive Therapy in Subjects With Partial Seizures
Status: Enrolling
Updated: 12/2/2016
GSK Investigational Site
mi
from
Crestview Hills, KY
Click here to add this to my saved trials
Study Evaluating LAMICTAL Extended-Release Therapy Added To Current Seizure Treatments In Patients With Partial Seizures
A Multicenter, Double-Blind, Randomized, Parallel-group Evaluation of LAMICTAL Extended-release Adjunctive Therapy in Subjects With Partial Seizures
Status: Enrolling
Updated:  12/2/2016
GSK Investigational Site
mi
from
Lexington, KY
Study Evaluating LAMICTAL Extended-Release Therapy Added To Current Seizure Treatments In Patients With Partial Seizures
A Multicenter, Double-Blind, Randomized, Parallel-group Evaluation of LAMICTAL Extended-release Adjunctive Therapy in Subjects With Partial Seizures
Status: Enrolling
Updated: 12/2/2016
GSK Investigational Site
mi
from
Lexington, KY
Click here to add this to my saved trials
Study Evaluating LAMICTAL Extended-Release Therapy Added To Current Seizure Treatments In Patients With Partial Seizures
A Multicenter, Double-Blind, Randomized, Parallel-group Evaluation of LAMICTAL Extended-release Adjunctive Therapy in Subjects With Partial Seizures
Status: Enrolling
Updated:  12/2/2016
GSK Investigational Site
mi
from
Louisville, KY
Study Evaluating LAMICTAL Extended-Release Therapy Added To Current Seizure Treatments In Patients With Partial Seizures
A Multicenter, Double-Blind, Randomized, Parallel-group Evaluation of LAMICTAL Extended-release Adjunctive Therapy in Subjects With Partial Seizures
Status: Enrolling
Updated: 12/2/2016
GSK Investigational Site
mi
from
Louisville, KY
Click here to add this to my saved trials
Study Evaluating LAMICTAL Extended-Release Therapy Added To Current Seizure Treatments In Patients With Partial Seizures
A Multicenter, Double-Blind, Randomized, Parallel-group Evaluation of LAMICTAL Extended-release Adjunctive Therapy in Subjects With Partial Seizures
Status: Enrolling
Updated:  12/2/2016
GSK Investigational Site
mi
from
Boston, MA
Study Evaluating LAMICTAL Extended-Release Therapy Added To Current Seizure Treatments In Patients With Partial Seizures
A Multicenter, Double-Blind, Randomized, Parallel-group Evaluation of LAMICTAL Extended-release Adjunctive Therapy in Subjects With Partial Seizures
Status: Enrolling
Updated: 12/2/2016
GSK Investigational Site
mi
from
Boston, MA
Click here to add this to my saved trials
Study Evaluating LAMICTAL Extended-Release Therapy Added To Current Seizure Treatments In Patients With Partial Seizures
A Multicenter, Double-Blind, Randomized, Parallel-group Evaluation of LAMICTAL Extended-release Adjunctive Therapy in Subjects With Partial Seizures
Status: Enrolling
Updated:  12/2/2016
GSK Investigational Site
mi
from
Detroit, MI
Study Evaluating LAMICTAL Extended-Release Therapy Added To Current Seizure Treatments In Patients With Partial Seizures
A Multicenter, Double-Blind, Randomized, Parallel-group Evaluation of LAMICTAL Extended-release Adjunctive Therapy in Subjects With Partial Seizures
Status: Enrolling
Updated: 12/2/2016
GSK Investigational Site
mi
from
Detroit, MI
Click here to add this to my saved trials